Recently, there is an increasing body of evidence that decreased expression of PTPN12 occurs in various human malignancies, including breast cancer, colon cancer, ovarian cancer and esophageal squamous cell carcinoma [9], [10], [13], [14]. Here, PTPN12 is linked to malignant colon neoplasm.